Integrated, sequential, and contingent screening for Down syndrome - local needs should drive methodology

Prenat Diagn. 2007 Feb;27(2):186-7. doi: 10.1002/pd.1634.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Biomarkers / blood
  • Cost-Benefit Analysis
  • Down Syndrome / blood
  • Down Syndrome / diagnosis*
  • Down Syndrome / economics
  • Female
  • Humans
  • Mass Screening / methods*
  • Pregnancy
  • Pregnancy Trimester, First
  • Pregnancy Trimester, Second
  • Prenatal Diagnosis / economics
  • Prenatal Diagnosis / methods*
  • Risk Assessment

Substances

  • Biomarkers